Joanna Robaczewska1,2, Kornelia Kędziora-Kornatowska1, Robert Kucharski3, Maria Nowak3, Marta Muszalik1, Maciej Kornatowski4, Józef Kędziora5. 1. a Department and Clinic of Geriatrics , Collegium Medicum UMK in Bydgoszcz , Poland. 2. b Life4Science Foundation , Poland. 3. c Psychoneurology of the Elderly Center at Sue Ryder Home, Pallmed LLC , Bydgoszcz , Poland. 4. d Medical University Lodz , Poland. 5. e Department of Biochemistry , Collegium Medicum UMK in Bydgoszcz , Poland.
Abstract
BACKGROUND: There is strong evidence that hypertension and depression are comorbid and oxidative stress is implicated in both pathologies. We aimed to elucidate the relationship between biochemical markers of the antioxidant-pro-oxidant equilibrium and depression in hypertension. METHODS: Blood was collected from patients diagnosed with depression, hypertension, or comorbid depression and hypertension and healthy age- and sex-matched controls. Whole blood reduced glutathione, erythrocyte superoxide dismutase (SOD-1), glutathione peroxidase (GPx-1), glutathione reductase (GR), malondialdehyde (MDA), and plasma hydrogen peroxide (H2O2) were assayed using spectrophotometry, and heme oxygenase (HO-1) levels were determined immunoenzymatically. RESULTS: Both hypertension and depression were associated with altered antioxidant-pro-oxidant profiles. Decreased GPx-1 and SOD-1 activities, increased GR activity, increased levels of GSH, and increased concentrations of MDA and H2O2 were observed in patients compared to controls. Inducible HO-1 was specifically decreased in patients with depression and was significantly associated with both the prevalence and severity of depressive symptoms. CONCLUSIONS: Heme oxygenase is a biological factor that might explain the relationship between inflammation, oxidative stress, and the biological and functional changes in brain activity in depression. HO-1 is a candidate depression biomarker and provides an avenue for novel preventative and diagnostic strategies against this disease.
BACKGROUND: There is strong evidence that hypertension and depression are comorbid and oxidative stress is implicated in both pathologies. We aimed to elucidate the relationship between biochemical markers of the antioxidant-pro-oxidant equilibrium and depression in hypertension. METHODS: Blood was collected from patients diagnosed with depression, hypertension, or comorbid depression and hypertension and healthy age- and sex-matched controls. Whole blood reduced glutathione, erythrocyte superoxide dismutase (SOD-1), glutathione peroxidase (GPx-1), glutathione reductase (GR), malondialdehyde (MDA), and plasma hydrogen peroxide (H2O2) were assayed using spectrophotometry, and heme oxygenase (HO-1) levels were determined immunoenzymatically. RESULTS: Both hypertension and depression were associated with altered antioxidant-pro-oxidant profiles. Decreased GPx-1 and SOD-1 activities, increased GR activity, increased levels of GSH, and increased concentrations of MDA and H2O2 were observed in patients compared to controls. Inducible HO-1 was specifically decreased in patients with depression and was significantly associated with both the prevalence and severity of depressive symptoms. CONCLUSIONS: Heme oxygenase is a biological factor that might explain the relationship between inflammation, oxidative stress, and the biological and functional changes in brain activity in depression. HO-1 is a candidate depression biomarker and provides an avenue for novel preventative and diagnostic strategies against this disease.
Authors: María Dolores Herrera; Carmen Mingorance; Rosalía Rodríguez-Rodríguez; Maria Alvarez de Sotomayor Journal: Ageing Res Rev Date: 2009-07-18 Impact factor: 10.895
Authors: D V Simic; J Mimic-Oka; M Pljesa-Ercegovac; A Savic-Radojevic; M Opacic; D Matic; B Ivanovic; T Simic Journal: J Hum Hypertens Date: 2006-02 Impact factor: 3.012
Authors: Priscila B Rosa; Luis E B Bettio; Vivian B Neis; Morgana Moretti; Isabel Werle; Rodrigo B Leal; Ana Lúcia S Rodrigues Journal: Purinergic Signal Date: 2019-11-25 Impact factor: 3.765
Authors: Katherine H Shutta; Raji Balasubramanian; Tianyi Huang; Shaili C Jha; Oana A Zeleznik; Candyce H Kroenke; Lesley F Tinker; Jordan W Smoller; Ramon Casanova; Shelley S Tworoger; JoAnn E Manson; Clary B Clish; Kathryn M Rexrode; Susan E Hankinson; Laura D Kubzansky Journal: Psychoneuroendocrinology Date: 2021-09-20 Impact factor: 4.693
Authors: Paulina Wigner; Ewelina Synowiec; Piotr Czarny; Michal Bijak; Paweł Jóźwiak; Janusz Szemraj; Piotr Gruca; Mariusz Papp; Tomasz Śliwiński Journal: J Cell Mol Med Date: 2020-04-13 Impact factor: 5.310
Authors: Gustavo Dias Ferreira; José Augusto Simões; Chamara Senaratna; Sanghamitra Pati; Pierre Fernando Timm; Sandro Rodrigues Batista; Bruno Pereira Nunes Journal: J Comorb Date: 2018-10-23